Kestra Medical Technologies, Ltd. KMTS NASDAQ

Kestra Medical Technologies, Ltd. (KMTS) reported total assets of $295.74M and total liabilities of $90.34M for fiscal year 2025, resulting in total equity of $205.41M.

The company held $237.6M in cash and short-term investments. Total debt stood at $44.31M, with net debt of $-193.28M. The Debt-to-Equity (D/E) ratio was 0.22 (conservative).

Current ratio is 6.72, indicating strong short-term liquidity. Interest coverage is -13.8x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (55/100) — Total assets $295.74M and equity $205.41M support the company's competitive scale
• VALUE (71/100) — Debt-to-Equity 0.22 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 49/100 with 2/7 criteria passed.

TERN

Terns Pharmaceuticals, Inc.

$52.71

+0.06%

NEOG

Neogen Corporation

$9.42

-1.98%

WVE

Wave Life Sciences Ltd.

$7.59

+2.71%

NVCR

NovoCure Limited

$12.17

+7.70%

PLSE

Pulse Biosciences, Inc.

$19.65

-2.36%

STAA

STAAR Surgical Company

$24.73

+1.23%

PGEN

Precigen, Inc.

$3.90

-2.01%

AZTA

Azenta, Inc.

$24.95

+2.84%